EUS BD vs ERCP TP for Pancreatic Cancer
BILPAL
Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) Compared to Standard Transpapillary Biliary Drainage (ERCP-TP) for Palliation of Jaundice in Unresectable Cancer of the Head of the Pancreas (BILPAL TRIAL)
1 other identifier
interventional
120
1 country
1
Brief Summary
This Endoscopic Ultrasound guided Biliary Drainage (EUS-BD) vs. Endoscopic Retrograde Cholangiopancreatography (ERCP-TP) trial (BILPAL) is a randomized controlled multicenter trial that will provide evidence whether or not traditional ERCP biliary drainage is to be performed in patients with obstruction in bile duct due to unresectable pancreatic head or periampullary tumor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pancreatic-cancer
Started Oct 2016
Shorter than P25 for not_applicable pancreatic-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2016
CompletedFirst Submitted
Initial submission to the registry
February 16, 2017
CompletedFirst Posted
Study publicly available on registry
February 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedFebruary 24, 2017
February 1, 2017
1.9 years
February 16, 2017
February 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of Stent Patency
Efficacy is measure by the evaluation of biliary stent patency at month 6 post randomization
6 months after randomization
Secondary Outcomes (6)
Safety evaluation: Assessment of number and frequency of procedure related adverse events within 1 month of the procedure
Within 1 month of procedure
Clinical Success
1 month from procedure
Technical Success
1 month from procedure
Survival duration
2 years from randomization
Serum bilirubin decrease
1 month from procedure
- +1 more secondary outcomes
Study Arms (2)
Endoscopic Ultrasound Guided Biliary Drainage
ACTIVE COMPARATOREndoscopic Ultrasound Guided biliary drainage with stent placement. EUS via either stomach or duodenum.
ERCP
PLACEBO COMPARATOREndoscopic Retrograde Cholangiopancreatography with transpapillary biliary stent placement only.
Interventions
Endoscopic Ultrasound Guided biliary drainage with stent placement;
Endoscopic Retrograde Cholangiopancreatography with transpapillary biliary stent placement
Eligibility Criteria
You may qualify if:
- Age between 18 and 90 years old
- Clinically indicated for biliary endoscopic drainage with Endoscopic Ultrasound guidance or ERCP
- CT scan has demonstrated a lesion in the pancreatic head area with metastases and/ or local tumor ingrowth preventing resection.
- CT with evidence of distant metastases or local tumor ingrowth into portal or mesenteric vessels (as defined by the tumor surrounding the vessel for at least 180 degrees of the circumference)
- A serum bilirubin level of \> 2.5mg/dL at randomization
- Deemed surgically unresectable
- Consents to participation in the randomized controlled trial
You may not qualify if:
- \> 90 years
- Severe comorbidity (Karnofsky \<50%)
- Any prior successful previous biliary drainage including ERCP and stenting, percutaneous biliary and surgical,
- Prior surgically altered pancreaticobiliary or gastroduodenal anatomy.
- Female of childbearing potential with a positive pregnancy test prior to the procedure or intends to become pregnant during the study.
- Currently participating in another device trial that has not completed the primary endpoint or that clinically interferes with the endpoints of this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medical College
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel Kahaleh, MD
Weill Medical College of Cornell University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Endoscopy
Study Record Dates
First Submitted
February 16, 2017
First Posted
February 24, 2017
Study Start
October 18, 2016
Primary Completion
September 1, 2018
Study Completion
October 1, 2018
Last Updated
February 24, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share